Company Filing History:
Years Active: 2012
Title: The Innovations of Joel E. Kleinman
Introduction
Joel E. Kleinman is a notable inventor based in Washington, DC. He has made significant contributions to the field of neuroscience, particularly in understanding schizophrenia. His work has implications for the development of antipsychotic drugs, showcasing the intersection of genetics and mental health.
Latest Patents
Kleinman holds a patent related to a schizophrenia-related isoform of KCNH2. This invention focuses on a novel primate-specific brain isoform of the potassium channel KCNH2 and its genetic association with the risk for schizophrenia. He has 1 patent that highlights his innovative approach to addressing complex mental health issues.
Career Highlights
Kleinman is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to engage in cutting-edge research and contribute to advancements in medical science.
Collaborations
Kleinman has worked alongside esteemed colleagues such as Daniel Weinberger and Stephen J. Huffaker. Their collaborative efforts have furthered the understanding of genetic factors in mental health disorders.
Conclusion
Joel E. Kleinman's work exemplifies the vital role of innovation in addressing mental health challenges. His contributions to the field of neuroscience continue to pave the way for future advancements in antipsychotic drug development.